NBIX icon

Neurocrine Biosciences

424 hedge funds and large institutions have $8.35B invested in Neurocrine Biosciences in 2022 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 161 increasing their positions, 143 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
424
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$89.6M
Puts
$79.5M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
101
$9.13M
102
$9.03M
103
$8.73M
104
$8.57M
105
$8.37M
106
$8.28M
107
$8.11M
108
$7.97M
109
$7.88M
110
$7.84M
111
$7.74M
112
$7.67M
113
$7.48M
114
$7.36M
115
$7M
116
$6.91M
117
$6.79M
118
$6.69M
119
$6.68M
120
$6.63M
121
$6.63M
122
$6.49M
123
$6.3M
124
$6.21M
125
$6.19M